Australia is investigating whether a blood clotting disorder case recorded on Friday is related to the AstraZeneca coronavirus vaccine, Deputy Chief Medical Officer Professor Michael Kidd said.
Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine.
“Investigators have not at this time confirmed a causal link with the Covid-19 AstraZeneca vaccine, but investigations are ongoing,” Kidd told a televised briefing.
He added that more details are expected to be known on Saturday.
Australia’s Therapeutic Goods Administration (TGA), the medicine and therapeutic regulatory agency, has said previously that AstraZeneca vaccine was not associated with an increase in the overall risk of blood clots.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Australia to reopen door to India, local Covid-19 cluster appears contained
Covid curbs reinstated in Sydney as Australian officials trace mystery case
Australia's most populous state reports first Covid-19 case in more than a month
Australia walks back 'racist' India ban after backlash
New Zealand resumes Perth travel bubble after Covid scare
Australia to consider proposal to suspend flights from India
Parts of Western Australia in three-day lockdown after small Covid-19 outbreak
Australia's Perth to enter snap lockdown after second Covid-19 case
New Zealand expects Australia 'travel bubble' to stay open despite new virus case